Media OutReach
Dr. Carl June and Dr. Michel Sadelain are being awarded the Broermann Medical Innovation Award 2025
- With prize money of one million euros, it is one of the most highly endowed medical awards in the world
- Awarded for groundbreaking pioneering work in cancer therapy using CAR-T cells
- Award Ceremony with Hessian Prime Minister Boris Rhein
GIESSEN, GERMANY – Newsaktuell – 18 September 2025. – The jury of the Broermann Medical Innovation Award (BMIA) is honoring Dr. Carl June (University of Pennsylvania) and Dr. Michel Sadelain (Columbia University) for their groundbreaking research in the field of CAR-T cell therapy. The Broermann Medical Innovation Award is being presented for the first time this year. With prize money of one million euros, it is among the most highly endowed awards for medical research worldwide.
A Revolution in Cancer Therapy
Dr. Carl June and Dr. Michel Sadelain are recognized for their pioneering roles in the genetic modification of T-cells, which enable these cells to identify, attack, and destroy cancer cells. They use synthetic receptors, so-called chimeric antigen receptors (CARs), which enable T cells to see and kill cancer cells. CAR-T cells achieve remarkable success rates in cancers such as leukemia, lymphomas, and myelomas; for other cancers, this new approach is still in the experimental phase.
Dr. Carl June, the Richard W. Vague Professor in Immunotherapy at the University of Pennsylvania Perelman School of Medicine, says: “I am deeply honored to receive the inaugural Broermann Medical Innovation Award together with my esteemed colleague Michel Sadelain. This award not only recognizes our decades of research but above all the transformative potential of CAR-T cell therapy for cancer patients worldwide.”

Dr. Michel Sadelain, Director of the Columbia Initiative in Cell Engineering and Therapy (CICET), says: “Receiving the Broermann Medical Innovation Award is an extraordinary honor for me and a recognition of the revolutionary power of CAR-T cell therapy. Together with Carl June, we have worked to turn the immune system into a precise weapon against cancer. Our work precisely symbolizes what the Broermann Award stands for: medical breakthroughs that fundamentally change patients’ lives. It fills me with profound gratitude to know that our research helps usher in a new era of cancer treatment and create hope for patients who were once considered incurable.”
CAR-T cell therapy has achieved remarkable success rates in treating cancers such as leukemia, lymphoma, and myeloma. Through their visionary research, Sadelain and June have ushered in a completely new era in cancer treatment.
Selection process by the renowned jury
The laureates of the Broermann Medical Innovation Award are selected by an outstanding scientific jury consisting of nine senior members of renowned institutes: Prof. Dr. Werner Seeger (Chair of the Broermann Medical Innovation Award), Prof. Dr. Karsten Krüger (Member of the Executive Board of Justus Liebig University Giessen), Prof. Dr. Isabelle Bekeredjian-Ding (Director Center of Infection, Inflammation and Immunity, University of Marburg), Prof. Dr. Britta Siegmund (Vice President of the German Research Foundation), Prof. Dr. Stefan Offermanns (Director of the Max Planck Institute for Heart and Lung Research), Prof. Dr. Otmar Wiestler (President of the Helmholtz Association), Prof. Dr. Dr. Gerd Geißlinger (Director of the Fraunhofer Institute for Clinical Pharmacology), Prof. Dr. Martina Brockmeier (President of the Leibniz Association), and Dr. Jan Liersch (Managing Director of Broermann Holding GmbH). Supported by a group of international reviewers, the committee evaluates all nominations in a multi-stage process that ensures the highest scientific quality and independence. The decision is based on strict selection criteria.
About the laureates
Dr. Carl June was born in Denver, USA, in 1953. He received his MD from Baylor College of Medicine in Houston and his postdoctoral training at the Fred Hutchinson Cancer Research Center in Seattle. Following a research career in the US Navy, June founded the Center for Cellular Immunotherapies (CCI) at the University of Pennsylvania in 1999 and established a leading interdisciplinary research initiative for cellular immunotherapies. In 2012, he received the prestigious Richard W. Vague Professorship.
Dr. Michel Sadelain was born in Paris, France, in 1960 and received his medical degree from the University of Paris in 1984 and his PhD from the University of Alberta, Canada in 1989, before conducting postdoctoral research at the Whitehead Institute for Biomedical Research at the Massachusetts Institute of Technology (MIT). In 1994, he joined Memorial Sloan Kettering Cancer Center in New York. Sadelain now serves as director of the Columbia Initiative in Cell Engineering and Therapy (CICET) center in New York, established in 2024, where he leads innovative cell therapy research.
Both scientists have received numerous scientific prizes for their pioneering contributions to cancer therapy.
https://www.asklepios.com
https://de.linkedin.com/company/asklepios
https://www.facebook.com/asklepioskliniken
https://www.instagram.com/asklepioskliniken/
https://www.asklepios.com/gesundheitsmagazin
http://www.youtube.com/asklepioskliniken
The issuer is solely responsible for the content of this announcement.
About the Broermann Medical Innovation Award
The Broermann Medical Innovation Award was established in 2024 by Dr. Bernard große Broermann, namesake and founder of the Asklepios Kliniken Group. Even during his lifetime, Dr. große Broermann was guided by the vision of creating an innovative
healthcare company that delivers real value to people. Under his leadership, Asklepios set new standards in medical innovation, making targeted investments in cutting-edge medical technology and digital solutions, thereby advancing patient care — values that also form the foundation of the Broermann Medical Innovation Award. The award carries forward his vision and continues to highlight the commitment of his foundation beyond his lifetime. With a record prize of one million euros, the award is presented in a formal ceremony at the Hessian State Chancellery in Wiesbaden by the current Hessian Prime Minister, Boris Rhein.
Media OutReach
New Documentary A MONA LISA OBSESSION from Discovery to debut December 14 in Southeast Asia
Owned by Frank Huang, an art collector and Taiwanese technology leader from Taiwan, this depiction of the Mona Lisa from his private collection adds a unique perspective to the ongoing conversation surrounding one of Leonardo da Vinci’s most iconic works.
The Mona Lisa has long captivated the world with her enigmatic smile and mysterious gaze – over centuries, many artistic interpretations inspired by the Mona Lisa have emerged, with scholars discovering more hidden details and subtle symbols, fueling the fascination of the original painting.
Catch A Mona Lisa Obsession in Southeast Asia on the Discovery Channel, Thursday, December 11, 2025 at 7:10 PM SGT and on Discovery Asia on Sunday, December 14 at 9:00 PM SGT.
****
Note to editors:
The issuer is solely responsible for the content of this announcement.
About Discovery Channel
Media OutReach
Financial Stress Keeps Singapore Awake, while Overall Well-Being in APAC Lags Behind Global Peers
Promotion of exercise culture and therapy may boost physical and mental health
The Singapore report of the Cigna Healthcare International Health Study 2025, released today encompasses more than 11,000 respondents across 13 markets, including 1,000 in Singapore and 4,000 across the Asia-Pacific region. The study reveals that physical, mental and financial well-being are the three aspects prioritized by Singapore residents. However, financial well-being is ranked the lowest with almost four in 10 (39%) rating their financial health as “fair” or “poor”.
Raymond Ng, CEO & Country Manager, Cigna Healthcare Singapore & Australia said: “Health and vitality are key to building resilient communities. It promises the well-being of our workforce and enables us to grow and prosper as a society. While vitality and well-being levels held firm among Singapore residents, more needs to be done in today’s uncertain environment to tackle stressors that can negatively impact their physical and mental well-being.”
The key indicators of vitality and well-being in Singapore are as follows:
| Vitality Score | Overall Well-Being
(% rating as “excellent” or “very good”)
|
Top Three Areas of Well-Being
(% rating as “excellent” or “very good” in 2025) |
| 2025: 61.2
2024: 61.4 |
2025: 34%
2024: 33% |
Family well-being: 44%
Mental well-being: 36% Physical well-being: 34% |
On a regional level, overall well-being in Asia Pacific lags behind the global average, with less than three in 10 (28%) Asia-Pacific respondents rating their overall well-being as “excellent” or “very good”, compared to four in 10 (41%) globally. While physical and mental well-being are the two most important aspects of well-being for respondents globally, financial well-being is more important for those in Asia Pacific, coming in as the third most important aspect. With financial well-being remaining the weakest aspect across the globe, there is a pressing need for governments and organizations to render support to address financial concerns.
Robert Peat, Chief Executive Officer, Asia Pacific, Cigna Healthcare said: “Asia Pacific continues to be one of the fastest growing regions in the world. To sustain this momentum, communities and employers need to recognize that healthy people are the foundation of a healthy economy and implement measures to close the gaps in their well-being.”
Sleepless in Singapore: Financial stress as the sleep killer
While mental well-being in Singapore remains stable with more than a third of respondents rating it as “excellent” or “very good” this year, eight in 10 (79%) respondents are stressed. Their greatest stressors are the current cost of living (53%); uncertainty about the future (47%); and personal finance (43%).
Stress affects more than mental and emotional health and can have huge implications on physical well-being. Our study reveals that disrupted sleep is the most common effect of stress among respondents in the nation, with close to half (48%) of respondents who are stressed reporting this effect, compared to 38% regionally.
Therapy remains underused by Singapore respondents. Despite nearly half (49%) of respondents reporting being negatively impacted by poor mental health, nearly nine in 10 (89%) say they did not receive counselling or therapy in the past 12 months, with 77% believing they do not need it. Given the impacts of stress and poor mental health on physical and overall well-being, more efforts are needed to raise awareness about the benefits of therapy and destigmatize seeking help.
Exercise culture runs strong in Singapore
More than a quarter (26%) of respondents in Singapore rate their exercise habits as “excellent” or “very good”.
When asked how they manage their weight, two-thirds (66%) said they exercise regularly, higher than the Asia-Pacific average of 61%; with only 4% of Singapore respondents turning to medication for weight management. The findings underscore a relatively strong exercise culture and the prioritization of healthy habits among those living in the nation. Communities and organizations may leverage the growing fitness trend to enhance physical well-being.
Cautious optimism around AI in healthcare
Close to half (47%) of Singapore respondents are positive about the impact of AI on healthcare, with 45% expecting it will reduce wait times within three years. This could have an outsized impact in Singapore, as respondents here are 29% more likely to have delayed or avoided getting care due to concern with wait times than their regional counterparts.
Additionally, almost half of Singapore respondents (48%) mention a reduction in human interaction as an expected change with the advent of AI. The challenge ahead is striking the right balance between efficiency and empathy.
The full findings of the report are available here.
Hashtag: #CignaHealthcare #CignaHealthcareInternationalHealthStudy #Health #Wellness #Wellbeing
https://www.cigna.com.sg/
https://www.linkedin.com/company/cigna-singapore/
https://www.facebook.com/cignasg/
https://www.instagram.com/cignasg/
The issuer is solely responsible for the content of this announcement.
Cigna Healthcare Singapore
Cigna Healthcare is a division of The Cigna Group, a global health company committed to creating a better future built on the health and vitality of every individual and every community. Cigna Healthcare is a health benefits provider that advocates for better health through every stage of life. We guide our customers through the healthcare system, empowering them with the information and insight they need to make the best choices for improving their health and vitality.
Cigna Healthcare Singapore is a strong believer of total health and wellness and prides itself on delivering personalized solutions for the health of our clients and customers. To achieve this, Cigna Healthcare Singapore works as one global team and in close partnership with its customers, network providers and communities to understand and address their diverse needs. Learn more at
www.cigna.com.sg
Media OutReach
SWISS REJU wins “JESSICA Best AI Body Slimming Award” with INDIBA
The JESSICA Beauty and Wellness Awards celebrate excellence across luxury beauty, healthcare and wellness. It is one of the most recognized beauty industry awards in Hong Kong. The organizer, JESSICA, is a major lifestyle and media company. For over 25 years, JESSICA has been reporting on fashion, lifestyle and business, as one of the most trustworthy and influential media sources in Hong Kong.
“We’re incredibly fortunate to win this new, Best AI Slimming Award with JESSICA,” said the spokesperson for SWISS REJU. “Our goal was to provide our guests with top medical aesthetic technologies. Platforms like BTL EXION and INDIBA, are exactly the type of top medical technologies which SWISS REJU is heavily investing in. The breathtaking results powered by AI, reflect the endless possibilities new technologies can bring to the beauty and slimming field”
The JESSICA Beauty and Wellness Awards is extremely selective and has a rigorous nominations and editorial selection process. Only brands that have been proven to provide genuine service and excellent results are eligible to compete. Amongst the Winners this year, are Australian organic brand “CANVAS” and Japanese household name “Panasonic VITALIFT” beauty appliances.
SWISS REJU, with its heavy investment in new and prestigious technologies such as INDIBA (recently approved in Europe under the Medical Device Regulation), offers a seamless blend of traditional wellness and innovation, allowing guests to experience what many considered to be one of the most effective slimming treatments in Hong Kong. INDIBA with its trademark Proionic 448khz technology, is loved by the Top 1% most influential users in the world, amongst them European royalties, celebrity footballers and international singers.
The recognition of this major annual Award, reaffirms SWISS REJU’s commitment to exceptional technology. It is the 12th annual award won by the brand, representing a new record.
SWISS REJU and integrative power of cutting edge technologies
SWISS REJU’s trademarked “K-Lipolysis” body contouring program offers winning technologies including INDIBA, BTL EXION, Winback, ATP LIPO X, amongst others. It is the unique contouring solution beauty lovers are craving for.
Hashtag: #SWISSREJU #熱光溶脂
The issuer is solely responsible for the content of this announcement.
-
Feature/OPED6 years agoDavos was Different this year
-
Travel/Tourism9 years ago
Lagos Seals Western Lodge Hotel In Ikorodu
-
Showbiz3 years agoEstranged Lover Releases Videos of Empress Njamah Bathing
-
Banking7 years agoSort Codes of GTBank Branches in Nigeria
-
Economy3 years agoSubsidy Removal: CNG at N130 Per Litre Cheaper Than Petrol—IPMAN
-
Banking3 years agoFirst Bank Announces Planned Downtime
-
Banking3 years agoSort Codes of UBA Branches in Nigeria
-
Sports3 years agoHighest Paid Nigerian Footballer – How Much Do Nigerian Footballers Earn












